Fideuram - Intesa Sanpaolo Private Banking’s Alnylam Pharmaceuticals ALNY Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.6M	Sell	35,077 -1,948	-5%	-$588K	0.32%	85
2026 Q1	$12.3M	Buy	37,025 +16,543	+81%	+$5.63M	0.43%	57
2025 Q4	$8.14M	Buy	+20,482	New	+$9.06M	0.29%	91

Other funds holding ALNY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's ALNY Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking reduced its Alnylam Pharmaceuticals (ALNY) stake by 5.3% in Q2 2026, selling an estimated $588K and leaving 35,077 shares worth $10.6M. The position accounts for 0.32% of the portfolio, ranked #85.

Fideuram - Intesa Sanpaolo Private Banking first reported a position in ALNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.3M in Q1 2026. 380 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Fideuram - Intesa Sanpaolo Private Banking held 35,077 shares of Alnylam Pharmaceuticals worth $10.6M as of Q2 2026.
Fideuram - Intesa Sanpaolo Private Banking sold 1,948 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $588K.
Alnylam Pharmaceuticals made up 0.32% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #85 holding.
Fideuram - Intesa Sanpaolo Private Banking first reported a position in Alnylam Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
Fideuram - Intesa Sanpaolo Private Banking's Alnylam Pharmaceuticals position peaked at $12.3M in Q1 2026.
380 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.